Comparing Eccentric Training and Conventional Therapy for Stroke Recovery
Characterization of the Neuromuscular and Biomechanical Properties of Spastic Myopathy-affected Muscles During the Generation of Passive and Active Force: the Effect of a Management Program Based on Eccentric Exercises.
This study is testing if a special type of exercise called eccentric training can help stroke survivors walk faster compared to regular therapy.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 20 Years to 75 Years |
| Sex | All |
| Sponsor | Clinique Du Parc de Belleville Academic / other |
| Locations | 1 site (Créteil) |
| Trial ID | NCT06140381 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of eccentric training versus conventional therapy in improving gait speed among sub-acute stroke survivors. Participants will be randomly assigned to either the Eccentric Training Group or the Conventional Therapy Group, with assessments conducted at three key time points: initial, intermediate, and final. The study will include a variety of evaluations, such as clinical health assessments, biomechanical assessments, and functional assessments, over a total duration of eight weeks. The primary focus is on enhancing neuromuscular parameters and muscle stiffness in the affected areas.
Who should consider this trial
Good fit: Ideal candidates are sub-acute stroke survivors with hemiparesis who have a BMI between 18.5 and 25.
Not a fit: Patients with ankle impairments, recent botulinum toxin injections, or significant cardiovascular or neurodegenerative disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved rehabilitation strategies for stroke survivors, enhancing their mobility and quality of life.
How similar studies have performed: Other studies have shown promising results with eccentric training approaches in rehabilitation, suggesting potential for success in this study as well.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subacute hemiparesis (\> 3 months) * BMI between 18.5 and 25 * Written consent to participate in the study. Exclusion Criteria: * Ankle impairment * Botulinum toxin injections in PF within the last 4 months before study inclusion * Medical contraindication for maximal effort * Neurodegenerative disorders * Cardiovascular disorders * History of epilepsy.
Where this trial is running
Créteil
- Wael Maktouf — Créteil, France (Recruiting)
Study contacts
- Principal investigator: Fedele Jean Michel, Investigator — Clinique Du Parc de Belleville
- Study coordinator: belghith kalthoum, Investigator
- Email: belghith.kalthoum@gmail.com
- Phone: 0649260709
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.